Cargando…

Cysteine-Rich Angiogenic Inducer 61 Serves as a Potential Serum Biomarker for the Remission of Adult-Onset Still's Disease

Objective: Adult-onset Still's disease (AOSD) is a rare, polygenic, systemic autoinflammatory disease. The aim of this study is to evaluate the serum levels of cysteine-rich angiogenic inducer 61 (Cyr61), a secreted, extracellular protein in AOSD patients. Methods: A total of 60 AOSD patients (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Yutong, Wang, Zhihong, Ye, Junna, Feng, Tienan, Wang, Fan, Chi, Huihui, Zhou, Zhuochao, Hu, Qiongyi, Liu, Honglei, Cheng, Xiaobing, Shi, Hui, Teng, Jialin, Yang, Chengde, Sun, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879423/ https://www.ncbi.nlm.nih.gov/pubmed/31824953 http://dx.doi.org/10.3389/fmed.2019.00266

Ejemplares similares

Serum sTREM-1 in adult-onset Still’s disease: a novel biomarker of disease activity and a potential predictor of the chronic course
por: Wang, Zhihong, et al.
Publicado: (2020)

Pregnancy Outcomes in Patients With Adult-Onset Still's Disease: A Cohort Study From China
por: Wang, Zhihong, et al.
Publicado: (2020)

Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still’s Disease
por: Sun, Yue, et al.
Publicado: (2020)

Interleukin-37 is increased in adult-onset Still’s disease and associated with disease activity
por: Chi, Huihui, et al.
Publicado: (2018)

Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still’s disease
por: Hu, Qiongyi, et al.
Publicado: (2019)

Tofacitinib in refractory adult-onset Still’s disease: 14 cases from a single centre in China
por: Hu, Qiongyi, et al.
Publicado: (2020)

A Cohort Study of Liver Involvement in Patients With Adult-Onset Still's Disease: Prevalence, Characteristics and Impact on Prognosis
por: Chi, Huihui, et al.
Publicado: (2020)

Circulating Neutrophil Extracellular Traps Signature for Identifying Organ Involvement and Response to Glucocorticoid in Adult-Onset Still’s Disease: A Machine Learning Study
por: Jia, Jinchao, et al.
Publicado: (2020)

The clinical pattern differentiates ANCA-positive infective endocarditis patients from ANCA-associated vasculitis patients: a 23 years’ retrospective cohort study in China and follow-ups
por: Wang, Fan, et al.
Publicado: (2022)

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences
por: Meng, Jianfen, et al.
Publicado: (2021)

Association of the Leukocyte Immunoglobulin‐like Receptor A3 Gene With Neutrophil Activation and Disease Susceptibility in Adult‐Onset Still’s Disease
por: Wang, Mengyan, et al.
Publicado: (2021)

Total metabolic lesion volume of lymph nodes measured by (18)F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still’s disease
por: Wan, Liyan, et al.
Publicado: (2021)

Value of the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the inflammatory myopathy population
por: Shi, Yunjing, et al.
Publicado: (2023)

Clinical characteristics of infective endocarditis in patients with antineutrophil cytoplasmic antibody or antiphospholipid antibody: a retrospective study in Shanghai
por: Zhou, Zhuochao, et al.
Publicado: (2020)

Cytomegalovirus Infection May Trigger Adult-Onset Still's Disease Onset or Relapses
por: Jia, Jinchao, et al.
Publicado: (2019)

Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases
por: Teng, Jialin, et al.
Publicado: (2020)

Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus
por: Zhou, Zhuochao, et al.
Publicado: (2020)

Neutrophil-derived lipocalin-2 in adult-onset Still’s disease: a novel biomarker of disease activity and liver damage
por: Jia, Jinchao, et al.
Publicado: (2020)

Methylenetetrahydrofolate Reductase 677T Allele Is a Risk Factor for Arterial Thrombosis in Chinese Han Patients with Antiphospholipid Syndrome
por: Tang, Zihan, et al.
Publicado: (2022)

Ferritin triggers neutrophil extracellular trap-mediated cytokine storm through Msr1 contributing to adult-onset Still’s disease pathogenesis
por: Jia, Jinchao, et al.
Publicado: (2022)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

Differential diagnostic performance of PET/CT in adult-onset still’s disease and lymphoma: a retrospective pilot study
por: Wan, Liyan, et al.
Publicado: (2022)

Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naïve systemic lupus erythematosus patients
por: Han, Jing, et al.
Publicado: (2022)

Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker
por: Hu, Qiongyi, et al.
Publicado: (2018)

Role of cysteine-rich angiogenic inducer 61 in fibroblast-like synovial cell proliferation and invasion in rheumatoid arthritis
por: JIE, LI-GANG, et al.
Publicado: (2015)

Role of cysteine-rich angiogenic inducer 61 in fibroblast-like synovial cell proliferation and invasion in rheumatoid arthritis
por: Jie, Li-Gang, et al.
Publicado: (2022)

Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer Cells
por: Bartkowiak, Kai, et al.
Publicado: (2021)

Blood‐based detection of lung cancer using cysteine‐rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study
por: Ac\ˇkar, Lucija, et al.
Publicado: (2021)

Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer
por: Li, Xinpeng, et al.
Publicado: (2018)

Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer
por: Li, Xinpeng, et al.
Publicado: (2022)

COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study
por: Pan, Haoyu, et al.
Publicado: (2022)

“Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort
por: Liu, Tingting, et al.
Publicado: (2020)

Current and emerging biological therapy in adult-onset Still’s disease
por: Ma, Yuning, et al.
Publicado: (2021)

Dickkopf-1/cysteine-rich angiogenic inducer 61 axis mediates palmitic acid-induced inflammation and apoptosis of vascular endothelial cells
por: Gan, Yi-Rong, et al.
Publicado: (2021)

Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis
por: Fan, Yong, et al.
Publicado: (2019)

CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis
por: Tang, Zihan, et al.
Publicado: (2023)

Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients
por: Shi, Hui, et al.
Publicado: (2017)

Activating transcription factor 3 inhibits angiotensin II-induced cardiomyocyte viability and fibrosis by activating the transcription of cysteine-rich angiogenic protein 61
por: Zhang, Yu, et al.
Publicado: (2022)

Prognostic significance of expression of cysteine-rich 61 and cyclooxygenase-2 in gastric cancer
por: Wang, Yan, et al.
Publicado: (2016)

Critical Role of Cysteine-Rich Protein 61 in Mediating the Activation of Renal Fibroblasts
por: Liu, Hang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_80phqvhctc7difof3t5d1uh015